1. Home
  2. AMST vs SLXN Comparison

AMST vs SLXN Comparison

Compare AMST & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMST
  • SLXN
  • Stock Information
  • Founded
  • AMST 2017
  • SLXN 2008
  • Country
  • AMST United States
  • SLXN Israel
  • Employees
  • AMST N/A
  • SLXN N/A
  • Industry
  • AMST Computer Software: Prepackaged Software
  • SLXN
  • Sector
  • AMST Technology
  • SLXN
  • Exchange
  • AMST Nasdaq
  • SLXN NYSE
  • Market Cap
  • AMST 7.4M
  • SLXN 5.0M
  • IPO Year
  • AMST 2020
  • SLXN N/A
  • Fundamental
  • Price
  • AMST $3.32
  • SLXN $1.27
  • Analyst Decision
  • AMST
  • SLXN Strong Buy
  • Analyst Count
  • AMST 0
  • SLXN 1
  • Target Price
  • AMST N/A
  • SLXN $9.00
  • AVG Volume (30 Days)
  • AMST 36.9K
  • SLXN 31.9M
  • Earning Date
  • AMST 02-10-2025
  • SLXN 02-25-2025
  • Dividend Yield
  • AMST N/A
  • SLXN N/A
  • EPS Growth
  • AMST N/A
  • SLXN N/A
  • EPS
  • AMST N/A
  • SLXN N/A
  • Revenue
  • AMST $86,115.00
  • SLXN N/A
  • Revenue This Year
  • AMST N/A
  • SLXN N/A
  • Revenue Next Year
  • AMST N/A
  • SLXN N/A
  • P/E Ratio
  • AMST N/A
  • SLXN N/A
  • Revenue Growth
  • AMST N/A
  • SLXN N/A
  • 52 Week Low
  • AMST $1.85
  • SLXN $0.21
  • 52 Week High
  • AMST $6.27
  • SLXN $13.56
  • Technical
  • Relative Strength Index (RSI)
  • AMST 46.51
  • SLXN N/A
  • Support Level
  • AMST $3.16
  • SLXN N/A
  • Resistance Level
  • AMST $3.60
  • SLXN N/A
  • Average True Range (ATR)
  • AMST 0.21
  • SLXN 0.00
  • MACD
  • AMST -0.00
  • SLXN 0.00
  • Stochastic Oscillator
  • AMST 36.07
  • SLXN 0.00

About AMST Amesite Inc.

Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.

Share on Social Networks: